665. Toxicity and Bio-Distribution of a GM-CSF-Expressing, Chimeric Oncolytic Adenovirus ONCOS-102

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34274-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oncolytic and Immunostimulatory Efficacy of a Targeted Oncolytic Poxvirus Expressing Human GM-CSF Following Intravenous Administration in a Rabbit Tumor Model

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

Prime-Boost Immunization by Both DNA Vaccine and Oncolytic Adenovirus Expressing GM-CSF and shRNA of TGF-β2 Induces Anti-Tumor Immune Activation

Oncotarget
Oncology
2017English

A Novel Ad5/11 Chimeric Oncolytic Adenovirus for Improved Glioma Therapy

International Journal of Oncology
Cancer ResearchOncology
2012English

Effective Gene-Viral Therapy of Leukemia by a New Fiber Chimeric Oncolytic Adenovirus Expressing TRAIL: In Vitro and in Vivo Evaluation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

639. Oncolytic Adenovirus Expressing IFN Alpha Works Synergistically With Chemoradiation

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Gm-CSF

2018English

Commanding CNS Invasion: GM-CSF

Immunity
Infectious DiseasesAllergyImmunology
2017English

117 “Arming” the Chimeric Oncolytic Adenovirus Enadenotucirev to Deliver Checkpoint Inhibitors and Other Therapeutics Directly to Tumours

European Journal of Cancer
Cancer ResearchOncology
2014English

Conditionally Replicative Adenovirus Expressing a Targeting Adapter Molecule Exhibits Enhanced Oncolytic Potency on CAR-deficient Tumors

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy